Explore our range of resources including sector case studies, webinars and recordings, opportunities and funding from our network, and useful guidance documents and links.
In the fourth #EvaluateDigiHealth 2021 webinar, commissioners and clinicians from within the NHS and social care system discussed their experience and understanding of evidence generated by digital health companies.
The third webinar in the #EvaluateDigiHealth 2021 series explored evidence generation for data-driven technologies in health care.
A free guide for innovators created by Boehringer Ingelheim (BI) with contributions from DigitalHealth.London and the AHSNs.
Relevant cyber and security services available to the NHS and social care, including guidance for connected medical devices.
A standard designed to help manufacturers of health IT software to evidence the clinical safety of products.
An online self-assessment tool that allows organisations to measure performance against the National Data Guardian’s data security standards.
NHSX’s Clinical Communications Procurement Framework and Spark Dynamic Purchasing System for remote monitoring, as well as information on Procurement services.
Information on WHO’s approach to digital health delivery, including the Global Strategy on Digital Health 2020-2024 and the latest news from the organisation.
The second webinar in the #EvaluateDigiHealth series featured a lively discussion about what help developers and commissioners of digital health need, and what help might be coming in the future.
In the first webinar in the 2021 #EvaluateDigiHealth series, leads for digital health companies critically discuss their experiences of navigating the evidence generation maze, including their challenges, achievements and failures.
The DigitalHealth.London Generator supported Macusoft to develop research questions through one-to-one sessions and to subsequently engage with academics.
The DigitalHealth.London Generator supported White Swan to pivot their product development roadmap to ensure they are clinically robust, as well as develop a roadmap for, and implement parts of, their evidence generation pathway.